share_log

Needham Reiterates Hold on Vertex Pharmaceuticals

Benzinga ·  Jul 26 17:35

Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment